[Advances in application of cell imprinting technology in biomedical field]. [PDF]
Zhao XM, Zhang ZY, Sun WJ, Qing GY.
europepmc +1 more source
[Long noncoding RNA HClnc1 promotes proliferation and migration of liver cancer cells by targeting RBBP5/KAT2B complex to enhance ODC1 transcription]. [PDF]
Feng Z +5 more
europepmc +1 more source
[Silencing DDX17 inhibits proliferation and migration of pulmonary arterial smooth muscle cells <i>in vitro</i> by decreasing mTORC1 activity]. [PDF]
Deng X +6 more
europepmc +1 more source
[Progress in clinical research related to viral hepatitis in 2025]. [PDF]
Ding Y, Li Y, Dou XG.
europepmc +1 more source
[Research progress on the pretreatment and analysis of prohibited components of glucocorticoids in cosmetics]. [PDF]
Liu L, Xiao XH, Fang JH, Li GK.
europepmc +1 more source
对54例丙型肝炎患者尿液特异指标检测,结果:抗-HCV阳性5/54例(9.2%)。HCVRNA阳性9/54例(16.7%)。急性HCV感染者,尿中抗-HCV检出率为2/6例(33%),较慢性者3/38例(7.9%)为高(P<0.05)。尿液HCVRNA全部出现在未经α-干扰素治疗的慢性患者中,故可用作判断干扰素疗效的指标之一。本文在尿中检出HCVRNA,提示HCV可经尿液污染环境。
doaj
[Study on the role and mechanism of quercetin promoting autophagy in HCCLM3 cells via STING signaling]. [PDF]
Chen L, Wu GZ, Zhu Y, Zhang TT.
europepmc +1 more source
[Treatment with interferon α-1b, interleukin-2, and thalidomide for persistent RUNX1::RUNX1T1 in a patient with KIT-mutated acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review]. [PDF]
Mi RH +5 more
europepmc +1 more source
siRNAs干扰EBNA1下调EBV阳性鼻咽癌细胞内ALOX12的表达
【目的】 利用RNA干扰技术抑制C666-1细胞中EB病毒核抗原1(EBNA1)的表达,探索氧化应激与抗氧化相关基因的表达变化65377; 【方法】 采用蛋白质印迹证实了能有效抑制EBNA1表达的干扰序列,使用甲基噻唑基四唑(MTT)方法检测C666-1细胞的存活率,利用实时定量PCR芯片技术探索了氧化应激与抗氧化相关基因的转录谱变化,并通过反转录聚合酶链反应(RT-PCR)和蛋白质印迹进行了验证65377;【结果】 EBNA1-1414和EBNA1-1437干扰序列转染C666-1细胞48 h后 ...
doaj
[Analysis of stimulating factors for serum copeptin based on liquid chromatography-tandem mass spectrometry]. [PDF]
Mu DN +8 more
europepmc +1 more source

